Introduction
Primary immunodeficiencies (PID) comprise a group of more than 200 different diseases. 1 The clinical severity ranges from mild to potentially life-threatening. Major efforts are currently being undertaken to develop methods for detection of PID in the neonatal period.
PCR based detection of signal joint T cell receptor excision circles (TRECs), extracted from Guthrie cards, has previously proven to be a valuable tool for identifying patients with severe combined immunodeficiencies (SCID). 2, 3, 4 Recently, a similar method for analysis of kappadeleting excision circles (KRECs) was described, allowing identification of patients with Xlinked agammaglobulinemia (XLA). 5 The early identification of XLA patients is highly desirable, as the incidence of chronic lung disease in these patients results from delayed diagnosis and is one of the most detrimental factors on the prognosis and quality of life. 6 To enable simultaneous screening of T-and B-cell deficiencies, we combined these assays into a novel triplex PCR method and evaluated its potential clinical application.
Patients and methods
Neonatal Guthrie card samples defect, n = 2) served as disease controls. All the included patients were retrospectively identified based on diagnoses made and none refused allocation of the stored original neonatal screening card. Dried blood spot samples were prepared within the first 72 hours after birth.
The KREC level of one of the XLA patients has been described in our previous publication.
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DNA elution from dried blood spot punches
Upon the approval of the institutional review board at the Karolinska University Hospital Huddinge, DNA from a single 3.2-mm punch of the dried blood disks was eluted into 24 µl of Generation DNA Elution Solution (Qiagen, Hilden, Germany) supplemented with 100 µg/ml yeast tRNA (Ambion, Austin, TX, USA), and 8 µl were subjected to real-time quantitative PCR (RT-qPCR) of TRECs, KRECs and β -actin (ACTB). 3 TREC and KREC copy numbers were normalized per µl blood, assuming that a 3.2-mm punch contains ~3 µl of whole blood.
The triplex RT-qPCR assay was optimized by primer limitation and probe concentration with primers and probes specific for the signal joint of TRECs and KRECs or for ACTB to assure equal amplification efficacies. 3, 7 ACTB amplification was used to assess the success of DNA extraction from the Guthrie cards.
Real-time quantitative triplex PCR
The RT-qPCR reactions were performed in a final volume of 20 µl containing 1XTaqMan
Gene 
Sequence analysis of PID genes
Genomic DNA, eluted from the dried blood spot punches of previously identified SCID patients, was used to amplify the coding regions of the RAG1, RAG2, IL2RG, IL-7RA or AK2 genes in order to verify mutations. 8 Subsequent to gel electrophoresis, PCR products were purified (MSB Spin PCRapace, Stratec, Berlin, Germany) and sent for direct sequencing (IZKF, University of Leipzig, Germany).
Results and Discussion

Cutoff values for reliable identification of SCID and XLA patients
Based on the KREC and TREC copy numbers of the included SCID and XLA patients and repeat testing of all 2.560 anonymized samples, suitable diagnostic cutoff scores were established at 15 TRECs/µl and 10 KRECs/µl. Given screening demands, cutoff scores were optimised to correctly identify the included samples from patients diagnosed with SCID or XLA with a sensitivity of 1.0 at expense of the specificity of the test (Fig. 1 ). Employing these cutoffs, the disease control samples from patients with CVID, IgAD and X-HIGM, as expected, all fell within the normal range. However, as the diagnosis of these antibody deficiency syndromes is often delayed in childhood, leading to development of lung damage and lymphoid proliferative disease, and given that effective treatement strategies exist in pediatric patients, efforts are indicated to allow an early-as-possible diagnosis of these diseases. 9, 10 Of interest, all 4 patients with AT showed a marked reduction of both TRECs and KRECs, and both patients with NBS were identified based on solely low KREC copy numbers (Fig. 1) . The TREC and KREC levels upon re-testing of the AT and NBS patients, as well as available clinical and routine laboratory information is given in supplementary table 1.
This implies that the method might also identify some patients with chromosome instability syndromes, who are commonly not recognised before the onset of symptoms in early 6 childhood. Repeat testing of all included PID patients, using either the original DNA eluate or DNA from a second dried blood spot, provided consistent results (data not shown).
To assess the overall reproducibility of the assay, 160 duplicate control samples were analyzed on different PCR systems (ABI 7500 and ViiA7). Within the dynamic range of copy numbers with excellent linearity, the intra-assay coefficient of variation was 1.2% for TRECs/µl and 1.4% for KRECs/µl. The inter-assay variance coefficient of variation was 3.5%
for TRECs/µl and 4.2% for KRECs/µl, indicating that our triplex RT-qPCR assay exhibits a robustness and reproducibility that meets diagnostic requirements.
Concordance of SCID immunophenotypes with TREC and KREC copy numbers
To conform with the diagnostic demands of neonatal screening, this study included only samples from the originally stored Guthrie cards of 18 SCID patients. All patients with ) immunophenotype, and none of the SCID patients with copy numbers of >10 KRECs/µl was found to have RAG1 mutations (Fig. 1) . 8 In patients with verified IL2RG mutations, KREC copy numbers were comparable to that of healthy newborns, reflecting the T -B + (NK + ) immunophenotype of X-SCID patients. 8 On the other hand, no mutations in the IL2RG gene were demonstrated in SCID patients with absent KRECs (Fig. 1) . Thus, our triplex PCR assay could be of value to guide the molecular diagnosis with regard to different types of SCID.
Diagnostic procedures for routine prospective Guthrie card analysis
Guthrie card samples with ACTB copy numbers below 1000/µl and concomitant reduction of TRECs and KRECs were referred to as 'inconclusive' due to a lack of DNA starting sample.
Thus, a second punch was repeatedly tested (n = 6; 0.23% of total), resulting in normal findings for 5 of these samples which is in the range of previous reports. 3, 4 Guthrie card samples with TREC or KREC copy numbers below the respective cutoff values were
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From 7 considered 'abnormal' and likewise subjected to repeat testing. Seven such samples (0.27% of total) were re-tested due to low TREC numbers (<15 TRECs/µl), eight samples (0.31% of total) due to low KREC numbers (<10 KRECs/µl), and one due to a combined reduction of both markers. The repeat testing of a second dried blood disk from the original cards yielded normal results for 10 samples (Fig. 2) . As the Guthrie cards used in this study were anonymized, the underlying cause for the T-or B-lymphopenia in the remaining 6 samples (0.23% of total) is unknown, but might be due to patients with the DiGeorge's syndrome (22q11 deletion syndrome), Trisomy 21, and others. 11 Furthermore, the presence of congenital abnormalities and complications due to prematurity have been shown to increase the number of abnormal test results from excision circle assays, as will the detection of additional combined immunodeficiencies such as DOCK8 deficiency. 12, 13 This observation is likely to be expanded to isolated abnormal KREC copy numbers, as presented herein for the included samples from NBS patients. The clinical significance of low KREC levels therefore deserves further investigation and will be the subject of two large-scale prospective studies in Sweden and Germany.
To assure the diagnostic suitability of the retesting procedure, all Guthrie card samples with previously 'normal' results were repeatedly tested using the original DNA eluate (data not shown). None of these samples reversed into either the 'abnormal' or 'inconclusive' category, indicating that the result of the analysis is inherently determined by the starting DNA sample, and not by the triplex PCR method. In the light of the screening purpose of our method, and
given that results in tested PID patients did not change upon re-analysis, the repeat testing of a second Guthrie card disk is a reliable and meaningful procedure that is also warranted in view of the low percentage of abnormal and inconclusive samples (0.86% of total).
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